Where I see patients (1)
Selected research
-
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy.
Cancer discovery
-
A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence.
Neuro-oncology
-
Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma.
Neurosurgery
Clinical trials
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
Adverse events will be classified and graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The proportion of CTCAE grade 3-5 toxicity within 1 year of radiation will be ...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 476-2212